Blood and plasma components are the individual parts of blood and plasma that are used for various medical procedures and therapies. 根据最新研究, the global blood and plasma components market is poised to grow by USD 14.8 亿期间 2023-2029, 复合年增长率为 4.82% 在预测期内.

该报告涵盖了市场规模和增长, 分割, 区域细分, 竞争格局, trends and strategies for global blood and plasma components market. 它提供了对市场的定量分析，使利益相关者能够利用当前的市场机会. 该报告还根据市场趋势和主要竞争对手的方法确定了最重要的机会和战略细分市场.

该行业报告提供了全球市场的市场估计和预测, 接下来是对产品的详细分析, 应用, 最终用户, 和地区. The global market for blood and plasma components can be segmented by product: plasma-derived products, transfusion. The plasma-derived products segment was the largest contributor to the global blood and plasma components market in 2022. Blood and plasma components market is further segmented by application: hematology, solid tumor management, 其他的. 据研究, the hematology segment had the largest share in the global blood and plasma components market. 基于最终用户, the blood and plasma components market is segmented into: hospitals and specialty clinics, 研究机构, diagnostics laboratories, 其他的. The hospitals and specialty clinics segment held the largest revenue share in 2022. 根据地区, the blood and plasma components market also can be divided into: 北美, 欧洲, 亚太, 事物 (中东和非洲), 拉美. 全球范围, North America made up the largest share of the blood and plasma components market.

市场细分
副产品: plasma-derived products, transfusion
按申请: hematology, solid tumor management, 其他的
按最终用户: hospitals and specialty clinics, 研究机构, diagnostics laboratories, 其他的
按地区: 北美, 欧洲, 亚太, 事物 (中东和非洲), 拉美

The report explores the recent developments and profiles of key vendors in the Global Blood and Plasma Components Market, including CSL Limited, Grifols, S.A., Takeda Pharmaceutical Company Limited, ADMA Biologics Inc., Biologics, 公司, C Pharma (Green Cross Corporation), Emergent BioSolutions, 公司, LFB S.A., 除其他外. 在这份报告中, 全面分析关键参与者及其策略，以了解市场的竞争前景.
*索取免费样品以获得完整的公司列表

报告范围
• To analyze and forecast the market size of the global blood and plasma components market.
• To classify and forecast the global blood and plasma components market based on product, 应用, 最终用户, 地区.
• To identify drivers and challenges for the global blood and plasma components market.
• 检查竞争性发展，例如合并 & 收购, 协议, 合作与伙伴关系, ETC。, in the global blood and plasma components market.
• To identify and analyze the profile of leading players operating in the global blood and plasma components market.

为什么选择这份报告
• Gain a reliable outlook of the global blood and plasma components market forecasts from 2023 到 2029 跨场景.
• 确定投资的增长领域.
• 通过公司简介和市场数据保持领先于竞争对手.
• 以 Excel 格式进行跨场景分析的市场预估.
• 三个月的战略咨询和研究支持.
• 为单用户许可证提供打印验证.